tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CYDY Stock Latest News

CytoDyn Resolves Lawsuit, Secures Payments, and Clears Debt
Company AnnouncementsCytoDyn Resolves Lawsuit, Secures Payments, and Clears Debt
16d ago
8K
CYDY
CytoDyn announces settlement with Amarex Clinical Research
PremiumThe Fly
CytoDyn announces settlement with Amarex Clinical Research
16d ago
CYDY
CytoDyn Announces Settlement with Amarex Clinical Research LLC
PremiumPress Releases
CytoDyn Announces Settlement with Amarex Clinical Research LLC
16d ago
CYDY
CytoDyn announces start of preclinical MASH study
PremiumThe Fly
CytoDyn announces start of preclinical MASH study
28d ago
CYDY
CytoDyn Announces Start of Preclinical MASH Study, Results Expected in Fall 2024
PremiumPress Releases
CytoDyn Announces Start of Preclinical MASH Study, Results Expected in Fall 2024
28d ago
CYDY
CytoDyn to Host Webcast to Provide Company Update
PremiumPress ReleasesCytoDyn to Host Webcast to Provide Company Update
2M ago
CYDY
CytoDyn issues letter to shareholders
PremiumThe Fly
CytoDyn issues letter to shareholders
2M ago
CYDY
May 2024 Letter to Shareholders
PremiumPress Releases
May 2024 Letter to Shareholders
2M ago
CYDY
CytoDyn to host business news update conference call
PremiumThe Fly
CytoDyn to host business news update conference call
5M ago
CYDY
CytoDyn to host business news update conference call
PremiumThe Fly
CytoDyn to host business news update conference call
5M ago
CYDY
CytoDyn to host business news update conference call
PremiumThe Fly
CytoDyn to host business news update conference call
5M ago
CYDY
CytoDyn Announces FDA Has Lifted Clinical Hold
PremiumPress Releases
CytoDyn Announces FDA Has Lifted Clinical Hold
5M ago
CYDY
CytoDyn says FDA has lifted clinical hold on leronlimab
PremiumThe FlyCytoDyn says FDA has lifted clinical hold on leronlimab
5M ago
CYDY
CytoDyn Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastoma
PremiumPress Releases
CytoDyn Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastoma
6M ago
CYDY
CytoDyn submits revised HIV clinical trial protocol to FDA
PremiumThe Fly
CytoDyn submits revised HIV clinical trial protocol to FDA
6M ago
CYDY
CytoDyn Releases Regulatory FD Disclosure Information
PremiumCompany Announcements
CytoDyn Releases Regulatory FD Disclosure Information
6M ago
8K
CYDY
CytoDyn Announces Executive Leadership Changes and Appointments
PremiumCompany Announcements
CytoDyn Announces Executive Leadership Changes and Appointments
6M ago
8K
CYDY
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
PremiumPress Releases
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
6M ago
CYDY
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
PremiumPress Releases
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
6M ago
CYDY
CytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
PremiumPress ReleasesCytoDyn Appoints Jacob Lalezari M.D. as CEO, Mitchell Cohen as Interim CFO
6M ago
CYDY
CytoDyn appoints Jacob Lalezari as CEO, Michael Cohen as interim CFO
PremiumThe Fly
CytoDyn appoints Jacob Lalezari as CEO, Michael Cohen as interim CFO
6M ago
CYDY
CytoDyn Announces Webcast to Provide Company Update
PremiumPress Releases
CytoDyn Announces Webcast to Provide Company Update
8M ago
CYDY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >